hotspot -WSS

hotspot

author：entertainment 2025-09-29 21:28:27 - browse：9498

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Patient advocates debate FDA's accelerated approval process

Wikipedia

hotspot

WSS

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Patient advocates debate FDA's accelerated approval process

Security flaws in third

Eliminate the waiting period for sterilization covered by Medicaid

Patient advocates debate FDA's accelerated approval process

Readout Newsletter: Merck, Vertex, and Viking updates

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Eliminate the waiting period for sterilization covered by Medicaid

In Memoriam: Notable people who died in 2023

Study says nonprofit hospitals fall short in charity care spending

ChatGPT in medicine: STAT answers readers' burning questions

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

How one medical school became remarkably diverse

How Robert F. Kennedy Jr. distorted vaccine science

At least 13 dead in Texas as scorching temps continue

Roche subsidiary Foundation Medicine opens new headquarters

leisure time

STAT wants to know your pick for a great summer read or listen

Hubble vs. James Webb telescope images: See the difference

Readout LOUD podcast: mifepristone case, GLP

Washington mulls new rules to avert another Change Healthcare

Dexcom's push to bring CGM to type 2 diabetes patients

Supreme Court mifepristone arguments center on docs' right to sue

explore

Wikipedia

hotspot

focus